Supplementary Data from Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody–drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors

Sylvie Rottey,Jeffrey Clarke,Kyaw Aung,Jean-Pascal Machiels,Ben Markman,Kimberley M. Heinhuis,Michael Millward,Martijn Lolkema,Sandip Pravin Patel,Paul de Souza,Matteo Duca,Giuseppe Curigliano,Armando Santoro,Takafumi Koyama, Michelle Brown,Heather Vezina,Chunsheng He,Quincy Siu-Chung Chu

crossref（2023）

引用 0|浏览0

暂无评分

摘要

Supplementary Data from Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody–drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要